RT Journal Article
SR Electronic
T1 Epigenetic Element-Based Transcriptome-Wide Association Study Identifies Novel Genes for Bipolar Disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.23.20161174
DO 10.1101/2020.07.23.20161174
A1 Yao, Shi
A1 Ding, Jing-Miao
A1 Wu, Hao
A1 Hao, Ruo-Han
A1 Rong, Yu
A1 Ke, Xin
A1 Guo, Jing
A1 Dong, Shan-Shan
A1 Guo, Yan
YR 2020
UL http://medrxiv.org/content/early/2020/08/01/2020.07.23.20161174.abstract
AB Bipolar disorder (BD) is a highly heritable neuropsychiatric disorder characterized by recurrent episodes of depression and mania. Since the signals identified by genome-wide association study (GWAS) often reside in the non-coding regions, understanding the biological relevance of these genetic loci has proven to be complicated. Transcriptome-wide association studies (TWAS) providing a powerful approach to identify novel disease risk genes and uncover possible causal genes at loci identified previously by GWAS. However, these methods did not consider the importance of epigenetic regulation in gene expression. Here, we developed a novel epigenetic element-based transcriptome-wide association study (ETWAS) that tests the effects of genetic variants on gene expression levels with the epigenetic features as prior and further mediates the association between predicted expression and BD. We conducted an ETWAS consisting of 20,352 cases and 31,358 controls and identified 44 transcriptome-wide significant hits. We found 14 conditionally independent genes, and 11 did not previously implicate with BD, which regarded as novel candidate genes, such as ASB16 in the cerebellar hemisphere (P = 9.29×10−8). We demonstrated that several genome-wide significant signals from the BD GWAS driven by genetically regulated expression, and conditioning of NEK4 explaining 90.1% of the GWAS signal. Additionally, ETWAS identified genes could explain heritability beyond that explained by GWAS-associated SNPs (P = 0.019). In conclusion, ETWAS is a powerful method, and we identified several novel candidate genes associated with BD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is supported by the National Natural Science Foundation of China (81872490), Innovative Talent Promotion Plan of Shaanxi Province for Young Sci-Tech New Star (2018KJXX-010), and the Fundamental Research Funds for the Central Universities. This study is also supported by the High-Performance Computing Platform of Xi'an Jiaotong University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data available upon request.